Serum paraoxonase activity is decreased in the active stage of Behcet's disease


Creative Commons License

KARAKUCUK S., Baskol G., Oner A., Baskol M., Mirza E., USTDAL M.

BRITISH JOURNAL OF OPHTHALMOLOGY, cilt.88, sa.10, ss.1256-1258, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

Özet

Aims: To evaluate paraoxonase1 (PON1) activities and malondialdehyde (MDA) levels, one of the end products of lipid peroxidation induced by reactive oxygen species in patients with Behcet's disease (BD) in the active stage.